In the second Alessi et al. analysis with single-agent ICI or ICI-combination with CTLA-4, KRAS-mutant NSCLC was the most common co-mutation in the SMARCA4 mutant subset (N = 17) [21]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.